Cargando…

Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation

AIMS: Atrial fibrillation (AF) and heart failure (HF) are the most common cardiac diseases and often coexist leading to increased mortality and morbidity compared with AF patients without HF. As shown previously, AF ablation using radio frequency (RF) in HF patients leads to a reduction of AF burden...

Descripción completa

Detalles Bibliográficos
Autores principales: Pott, Alexander, Jäck, Saskia, Schweizer, Christiane, Baumhardt, Michael, Stephan, Tilman, Rattka, Manuel, Weinmann, Karolina, Bothner, Carlo, Scharnbeck, Dominik, Keßler, Mirjam, Rottbauer, Wolfgang, Dahme, Tillman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524096/
https://www.ncbi.nlm.nih.gov/pubmed/32578969
http://dx.doi.org/10.1002/ehf2.12735
_version_ 1783588488618180608
author Pott, Alexander
Jäck, Saskia
Schweizer, Christiane
Baumhardt, Michael
Stephan, Tilman
Rattka, Manuel
Weinmann, Karolina
Bothner, Carlo
Scharnbeck, Dominik
Keßler, Mirjam
Rottbauer, Wolfgang
Dahme, Tillman
author_facet Pott, Alexander
Jäck, Saskia
Schweizer, Christiane
Baumhardt, Michael
Stephan, Tilman
Rattka, Manuel
Weinmann, Karolina
Bothner, Carlo
Scharnbeck, Dominik
Keßler, Mirjam
Rottbauer, Wolfgang
Dahme, Tillman
author_sort Pott, Alexander
collection PubMed
description AIMS: Atrial fibrillation (AF) and heart failure (HF) are the most common cardiac diseases and often coexist leading to increased mortality and morbidity compared with AF patients without HF. As shown previously, AF ablation using radio frequency (RF) in HF patients leads to a reduction of AF burden, an increase of left ventricular ejection fraction (LVEF) and consequently to reduced hospitalization and mortality. Previous AF ablation studies on HF patients have been liberal about additional targets beyond pulmonary vein isolation (PVI). Thus, the aim of this study was to assess systematically the impact of a straightforward PVI‐only strategy on LVEF, NYHA functional class, and cardiovascular hospitalization rate in HF patients. METHODS AND RESULTS: Out of 414 consecutive patients undergoing PVI, only with the cryoballoon 113 patients with reduced LVEF [mean: 38.4 ± 10.8%, reduced ejection fraction (rEF) group] and 301 patients with normal LVEF (>55%) at baseline were identified [normal ejection fraction (nEF) group]. Remarkably, even though freedom from arrhythmia recurrence after 1 year was significantly lower in the rEF group (64.9%) compared with the nEF group (71.2%, P = 0.036), mean LVEF improved from 38.4 ± 10.8% to 52.5 ± 17.2% (P < 0.001) after cryoballoon ablation in the rEF group. Accordingly, HF‐related symptoms as well as hospitalization rate declined significantly in the rEF group during follow‐up compared with baseline. CONCLUSIONS: The results of the present study suggest that catheter ablation restricted to a straightforward PVI‐only strategy using the cryoballoon leads to improved left ventricular ejection fraction as well as improvement of NYHA functional class and increased freedom from cardiovascular rehospitalization.
format Online
Article
Text
id pubmed-7524096
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75240962020-10-02 Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation Pott, Alexander Jäck, Saskia Schweizer, Christiane Baumhardt, Michael Stephan, Tilman Rattka, Manuel Weinmann, Karolina Bothner, Carlo Scharnbeck, Dominik Keßler, Mirjam Rottbauer, Wolfgang Dahme, Tillman ESC Heart Fail Original Research Articles AIMS: Atrial fibrillation (AF) and heart failure (HF) are the most common cardiac diseases and often coexist leading to increased mortality and morbidity compared with AF patients without HF. As shown previously, AF ablation using radio frequency (RF) in HF patients leads to a reduction of AF burden, an increase of left ventricular ejection fraction (LVEF) and consequently to reduced hospitalization and mortality. Previous AF ablation studies on HF patients have been liberal about additional targets beyond pulmonary vein isolation (PVI). Thus, the aim of this study was to assess systematically the impact of a straightforward PVI‐only strategy on LVEF, NYHA functional class, and cardiovascular hospitalization rate in HF patients. METHODS AND RESULTS: Out of 414 consecutive patients undergoing PVI, only with the cryoballoon 113 patients with reduced LVEF [mean: 38.4 ± 10.8%, reduced ejection fraction (rEF) group] and 301 patients with normal LVEF (>55%) at baseline were identified [normal ejection fraction (nEF) group]. Remarkably, even though freedom from arrhythmia recurrence after 1 year was significantly lower in the rEF group (64.9%) compared with the nEF group (71.2%, P = 0.036), mean LVEF improved from 38.4 ± 10.8% to 52.5 ± 17.2% (P < 0.001) after cryoballoon ablation in the rEF group. Accordingly, HF‐related symptoms as well as hospitalization rate declined significantly in the rEF group during follow‐up compared with baseline. CONCLUSIONS: The results of the present study suggest that catheter ablation restricted to a straightforward PVI‐only strategy using the cryoballoon leads to improved left ventricular ejection fraction as well as improvement of NYHA functional class and increased freedom from cardiovascular rehospitalization. John Wiley and Sons Inc. 2020-06-24 /pmc/articles/PMC7524096/ /pubmed/32578969 http://dx.doi.org/10.1002/ehf2.12735 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research Articles
Pott, Alexander
Jäck, Saskia
Schweizer, Christiane
Baumhardt, Michael
Stephan, Tilman
Rattka, Manuel
Weinmann, Karolina
Bothner, Carlo
Scharnbeck, Dominik
Keßler, Mirjam
Rottbauer, Wolfgang
Dahme, Tillman
Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
title Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
title_full Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
title_fullStr Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
title_full_unstemmed Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
title_short Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
title_sort atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524096/
https://www.ncbi.nlm.nih.gov/pubmed/32578969
http://dx.doi.org/10.1002/ehf2.12735
work_keys_str_mv AT pottalexander atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT jacksaskia atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT schweizerchristiane atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT baumhardtmichael atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT stephantilman atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT rattkamanuel atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT weinmannkarolina atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT bothnercarlo atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT scharnbeckdominik atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT keßlermirjam atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT rottbauerwolfgang atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation
AT dahmetillman atrialfibrillationablationinheartfailurepatientsimprovedsystolicfunctionaftercryoballoonpulmonaryveinisolation